Blog

Oct 30, 2024

BIO-TECHNE RECEIVES CiteAb'S ELISA KIT SUPPLIER OF THE YEAR AND SPATIAL BIOLOGY INNOVATION AWARDS

Apr 01, 2024, 07:00 ET Share this article MINNEAPOLIS, April 1, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TEC

Oct 30, 2024

Archon emerges from stealth with $20M and 'antibody cages' to power up drug development | TechCrunch

Archon Biosciences, a biotech startup putting AI to work designing novel biomolecules, has just emerged from stealth wit

Oct 30, 2024

Innate immune control of influenza virus interspecies adaptation via IFITM3 | Nature Communications

Nature Communications volume 15, Article number: 9375 (2024) Cite this article Metrics details Influenza virus pandemics

Oct 30, 2024

Fast And Accurate Detection Of Alzheimer's Disease Targets With SimpleStep ELISA Kits And SPECTROstar Nano

By Mallori Milligan, Abcam, Scott Detmer, Abcam, and Carl Peters, BMG LABTECH This content is brought to you by Abcam, a

Oct 30, 2024

Coya Therapeutics' High-Dose Interleukin-2 Misses The Mark In Mid-Stage Alzheimer's Study

On Tuesday, Coya Therapeutics, Inc. (NASDAQ:COYA) released results from the placebo-controlled Phase 2 trial of LD IL-2

Oct 30, 2024

Former Seagen CEO David Epstein to lead new biotech with VEGF bifunctional antibody

David Ep­stein, who was the CEO of Seagen when it was ac­quired by Pfiz­er for $43 bil­lion last year, is join­ing a … G

Oct 30, 2024

SfN 2024: Atlas antibodies and the MolBoolean™

Carolyn Marks and Joel Svensson In this interview, conducted at SfN 2024 in Chicago, News Medical speaks with Joel Svens

Oct 29, 2024

Characterization of anti-AAV2 neutralizing antibody levels in sheep prior to and following intravitreal AAV2.7m8 injection | Gene Therapy

Gene Therapy (2024)Cite this article Metrics details Gene augmentation therapy is a promising treatment for incurable, b

Oct 29, 2024

SARS-CoV-2 variants induce increased inflammatory gene expression but reduced interferon responses and heme synthesis as compared with wild type strains | Scientific Reports

Scientific Reports volume 14, Article number: 25734 (2024) Cite this article Metrics details SARS-CoV-2 variants of conc

Oct 28, 2024

Delayed Antibody Treatment May Improve Efficacy of mRNA Vaccines - News Center

Investigators led by Pablo Penaloza-MacMaster, PhD, associate professor of Microbiology-Immunology, have discovered that

Oct 28, 2024

Beyond the lab: antibodies

Supported by: Published: 24 October 2024 This report provides insights into the latest breakthroughs in antibody researc

Oct 28, 2024

San Antonio 2-year-old fights autoimmune disease | kens5.com

SAN ANTONIO — Alaia Hernandez spent her first birthday in the hospital. Her condition with hypogammaglobulinemia can cha